The global exoskeleton market was valued at USD 590.0 million in 2025 and is expected to grow from USD 694.4 million in 2026 to USD 1,790.0 million by 2033, registering a CAGR of 14.5% during the forecast period from 2026 to 2033. North America accounted for the largest revenue share of 44.1% in 2025, reflecting its strong adoption of advanced rehabilitation and industrial technologies. Market expansion is being supported by the rapidly growing global geriatric population, increasing adoption of wearable robotic devices across healthcare, automotive, military, defense, and construction industries, along with the rising prevalence of stroke and mobility-related disorders. As technological innovation continues to improve performance, comfort, and affordability, exoskeleton systems are becoming increasingly valuable for both medical rehabilitation and industrial workforce support.

Market Size & Forecast

• Market size in 2025: USD 590.0 million
• Estimated market size in 2026: USD 694.4 million
• Projected market size by 2033: USD 1,790.0 million
• CAGR (2026-2033): 14.5%

The increasing incidence of spinal cord injuries (SCI) remains one of the strongest factors driving global demand for exoskeleton technologies. According to the National Spinal Cord Injury Statistical Center (NSCISC), around 17,730 new spinal cord injuries are diagnosed annually in the United States, while nearly 291,000 individuals are currently living with these conditions. Such injuries often require long-term rehabilitation and mobility assistance, encouraging healthcare providers to adopt robotic wearable solutions that help improve patient independence, mobility, and overall quality of life. The growing need for effective rehabilitation technologies is expected to sustain market growth throughout the forecast period.

Exoskeleton systems have gained widespread acceptance across several industries due to their ability to improve employee safety, reduce physical strain, and enhance productivity. As a major segment within the wearable robot market, these solutions are increasingly utilized in manufacturing, logistics, healthcare, and construction. Growing demand has encouraged the emergence of innovative startups focused on rehabilitation technologies and wearable robotic systems. Continuous advancements in lightweight materials, artificial intelligence, and motion control are enabling manufacturers to introduce next-generation products. In January 2026, RoboCT introduced its lightweight GoGo Exoskeleton series during CES 2026, expanding beyond clinical rehabilitation into consumer mobility applications. The AI-powered wearable weighs only 2.3 kg and provides adaptive support for walking, sitting, balancing, and other daily movements, serving individuals recovering from stroke, neurodegenerative disorders, and age-related mobility limitations.

Download a free sample copy of the Exoskeleton Market report to understand detailed coverage and inclusions in the final report

The growing number of spinal cord injury patients continues to strengthen demand for robotic assistive devices within healthcare environments. Healthcare professionals increasingly recommend wearable exoskeletons to improve rehabilitation outcomes, restore mobility, and reduce long-term disability. According to the United Spinal Association, approximately 250,000 to 390,000 individuals in the U.S. were living with spinal cord injuries in September 2025, while nearly 18,000 new cases occur annually, primarily due to vehicle accidents and falls. Patients frequently experience secondary complications such as chronic pain, depression, respiratory disorders, bowel and bladder dysfunction, pressure injuries, and muscle spasticity. These challenges further increase the importance of advanced rehabilitation technologies, making exoskeleton systems an essential component of patient recovery programs.

Musculoskeletal disorders among industrial workers also contribute significantly to market growth. Construction workers frequently experience occupational overuse syndrome (OOS), cumulative trauma disorders (CTD), and repetitive strain injuries (RSI) due to physically demanding work environments. According to estimates published by the World Health Organization in July 2022, nearly 1.71 billion people worldwide suffer from musculoskeletal disorders, including neck pain, lower back pain, fractures, osteoarthritis, rheumatoid arthritis, and amputations. Likewise, the U.S. Bureau of Labor Statistics reported approximately 502,380 occupation-related musculoskeletal disorder cases across multiple industries during 2022. Exoskeleton technologies help reduce worker fatigue, minimize injury risks, enhance lifting capacity, and improve workplace productivity, making them increasingly attractive across industrial sectors.

Technological innovation continues to reshape the exoskeleton industry by improving product efficiency, user comfort, and intelligent mobility assistance. Artificial intelligence, machine learning, advanced sensors, and lightweight materials are enabling manufacturers to design smarter wearable robotic systems suitable for both healthcare and industrial applications. Rising adoption across manufacturing facilities, logistics operations, automotive production, warehouses, and construction sites continues to expand market penetration. In May 2025, Wandercraft initiated clinical trials for its AI-powered Personal Exoskeleton, utilizing NVIDIA AI and simulation technologies to provide adaptive walking support for individuals affected by spinal cord injuries, stroke, and severe mobility impairments. These advancements are expected to accelerate commercial adoption while improving patient rehabilitation outcomes.

Looking for more specific insights? Customize this report to suite your business needs

Insurance reimbursement policies are also becoming increasingly favorable for exoskeleton technologies, improving patient accessibility and affordability. Several countries have started recognizing specific robotic rehabilitation systems within public and private healthcare reimbursement frameworks. Germany has emerged as an important example where selected exoskeleton systems qualify for insurance procurement. Similarly, in November 2023, ReWalk Robotics Ltd. welcomed the publication of the Centers for Medicare & Medicaid Services (CMS) Calendar Year 2024 Home Health Prospective Payment System Rule. Effective January 1, 2024, the regulation officially classified exoskeleton devices under the Medicare brace benefit category, supporting wider patient access and encouraging greater adoption across rehabilitation centers.

Competition within the exoskeleton market remains strong as established manufacturers continue investing in product innovation, strategic collaborations, and research initiatives to strengthen their market positions. Leading companies focus on developing advanced wearable robotic systems capable of serving healthcare, military, industrial, and rehabilitation applications. In March 2023, Svaya Robotics developed both a quadruped robot and a wearable exoskeleton specifically designed for Indian soldiers, helping them carry heavy equipment while reducing fatigue during long-distance movement. While major companies continue expanding research and development capabilities, emerging players are introducing cost-effective technologies that broaden accessibility and stimulate competitive innovation across the global market.

Explore Grand View Horizon to see global and regional level statistics related to the Exoskeleton Market

Key Market Trends & Insights

• By mobility: Mobile segment held the largest share of 62.64% in 2025.
• By technology: Powered segment held the largest revenue share with 71.40% in 2025.
• By extremity: Lower body segment dominated the market in terms of revenue share with 40.72% in 2025.
• By end use: Healthcare segment dominated the market in terms of revenue share with 48.76% in 2025.

The mobile segment accounted for the largest market share of 62.64% in 2025 due to increasing demand for wearable systems that allow users to move freely across healthcare, industrial, and rehabilitation environments. Mobile exoskeletons improve flexibility, enhance mobility, and support a wider range of daily activities.

The powered segment captured the highest revenue share of 71.40% in 2025 as electrically powered exoskeletons provide greater strength assistance, intelligent movement control, and improved rehabilitation outcomes. Continuous innovation in battery technology and AI-powered control systems is further supporting adoption.

The lower body segment generated the largest revenue share of 40.72% in 2025 because lower limb exoskeletons are extensively used for patients recovering from spinal cord injuries, stroke, and mobility disorders. Their growing use in rehabilitation centers continues to strengthen segment growth.

The healthcare segment accounted for the largest revenue share of 48.76% in 2025 owing to rising demand for robotic rehabilitation solutions across hospitals, rehabilitation centers, and long-term care facilities. Growing patient populations requiring mobility assistance continue to support healthcare sector dominance.

Looking for a report customized to your requirements? Explore our Custom Research Offering

Conclusion

The global exoskeleton market is expected to witness substantial growth over the coming years, driven by increasing demand for rehabilitation technologies, rising industrial safety requirements, expanding elderly populations, and continuous technological advancements. The growing burden of spinal cord injuries, musculoskeletal disorders, and stroke is encouraging wider adoption of wearable robotic systems across healthcare settings, while industries are increasingly utilizing exoskeletons to improve worker productivity and reduce physical strain. Supportive reimbursement policies, AI-powered product innovations, and strategic investments by leading manufacturers are further strengthening market expansion. As adoption continues to increase across both medical and industrial applications, the exoskeleton market is well positioned to achieve sustained long-term growth through 2033.